Tafazzin / TAZ antibody, N-term

GeneTex

Tafazzin / TAZ antibody, N-term

9

WB: 1:1000. IHC-P: 1:50-1:100. FACS: 1:10-1:50. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.

Liquid

TAFAZZIN

tafazzin, phospholipid-lysophospholipid transacylase

BTHS; CMD3A; EFE; EFE2; G4.5; LVNCX; protein G4.5; tafazzin; TAZ; Taz1

Tafazzin

This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced; the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known. [provided by RefSeq, Jul 2008]

-20°C or -80°C,2°C to 8°C

12352203